UNIVERSIDAD NACIONAL DE LA PLATA

Bibliografía
Richard D, Lin Q, Timofeeva E (2002) The corticotropin‐releasing factor family of peptides and
CRF receptors: their roles in the regulation of energy balance. European journal of
pharmacology 440:189‐197.
Riday TT, Fish EW, Robinson JE, Jarrett TM, McGuigan MM, Malanga CJ (2012) Orexin‐1 receptor
antagonism does not reduce the rewarding potency of cocaine in Swiss‐Webster mice.
Brain research 1431:53‐61.
Robison CL, Meyerhoff JL, Saviolakis GA, Chen WK, Rice KC, Lumley LA (2004) A CRH1 antagonist
into the amygdala of mice prevents defeat‐induced defensive behavior. Annals of the
New York Academy of Sciences 1032:324‐327.
Rodd‐Henricks ZA, McKinzie DL, Crile RS, Murphy JM, McBride WJ (2000) Regional heterogeneity
for the intracranial self‐administration of ethanol within the ventral tegmental area of
female Wistar rats. Psychopharmacology 149:217‐224.
Rodd ZA, Bell RL, McQueen VK, Davids MR, Hsu CC, Murphy JM, Li TK, Lumeng L, McBride WJ
(2005) Chronic ethanol drinking by alcohol‐preferring rats increases the sensitivity of the
posterior ventral tegmental area to the reinforcing effects of ethanol. Alcoholism,
clinical and experimental research 29:358‐366.
Rondou P, Haegeman G, Van Craenenbroeck K (2010) The dopamine D4 receptor: biochemical
and signalling properties. Cell Mol Life Sci 67:1971‐1986.
Rothwell NJ (1990) Central effects of CRF on metabolism and energy balance. Neuroscience and
biobehavioral reviews 14:263‐271.
Sah P, Faber ES, Lopez De Armentia M, Power J (2003) The amygdaloid complex: anatomy and
physiology. Physiological reviews 83:803‐834.
Sahr AE, Sindelar DK, Alexander‐Chacko JT, Eastwood BJ, Mitch CH, Statnick MA (2008)
Activation of mesolimbic dopamine neurons during novel and daily limited access to
palatable food is blocked by the opioid antagonist LY255582. American journal of
physiology Regulatory, integrative and comparative physiology 295:R463‐471.
Sakanaka M, Shibasaki T, Lederis K (1986) Distribution and efferent projections of corticotropinreleasing
factor‐like immunoreactivity in the rat amygdaloid complex. Brain research
382:213‐238.
Sakanaka M, Shibasaki T, Lederis K (1987) Corticotropin releasing factor‐like immunoreactivity
in the rat brain as revealed by a modified cobalt‐glucose oxidase‐diaminobenzidine
method. The Journal of comparative neurology 260:256‐298.
Sakurai T (1999) Orexins and orexin receptors: implication in feeding behavior. Regulatory
peptides 85:25‐30.
Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richarson JA,
Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty
DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M (1998) Orexins and
orexin receptors: a family of hypothalamic neuropeptides and G protein‐coupled
receptors that regulate feeding behavior. Cell 92:1 page following 696.
Sakurai T, Moriguchi T, Furuya K, Kajiwara N, Nakamura T, Yanagisawa M, Goto K (1999)
Structure and function of human prepro‐orexin gene. J Biol Chem 274:17771‐17776.
Salamone JD, Correa M (2012) The mysterious motivational functions of mesolimbic dopamine.
Neuron 76:470‐485.
Salamone JD, Correa M (2013) Dopamine and food addiction: lexicon badly needed. Biological
psychiatry 73:e15‐24.
Sanacora G, Kershaw M, Finkelstein JA, White JD (1990) Increased hypothalamic content of
preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and
its regulation by food deprivation. Endocrinology 127:730‐737.
150